BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24314884)

  • 81. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resection.
    Varlotto JM; Medford-Davis LN; Recht A; Flickinger J; Yao N; Hess C; Reed MF; Toth J; Zander DS; DeCamp MM
    Chest; 2013 May; 143(5):1365-1377. PubMed ID: 23715196
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    Tsutani Y; Handa Y; Shimada Y; Ito H; Ikeda N; Nakayama H; Yoshimura K; Okada M
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1244-1252.e1. PubMed ID: 33213872
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
    J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
    Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC.
    Husain ZA; Kim AW; Yu JB; Decker RH; Corso CD
    Clin Lung Cancer; 2015 Nov; 16(6):e183-7. PubMed ID: 25979646
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non-Small Cell Lung Cancer.
    Altorki NK; Kamel MK; Narula N; Ghaly G; Nasar A; Rahouma M; Lee PC; Port JL; Stiles BM
    J Thorac Oncol; 2016 Nov; 11(11):1984-1992. PubMed ID: 27496651
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.
    Yendamuri S; Komaki RR; Correa AM; Allen P; Wynn B; Blackmon S; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Vaporciyan AA; Walsh GL; Mehran RJ
    J Thorac Oncol; 2007 Nov; 2(11):1022-8. PubMed ID: 17975494
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
    Grieco CA; Simon CJ; Mayo-Smith WW; DiPetrillo TA; Ready NE; Dupuy DE
    J Vasc Interv Radiol; 2006 Jul; 17(7):1117-24. PubMed ID: 16868164
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Surgical Outcome of Sublobar Resection in High-risk Patients with Non-small Cell Lung Cancer].
    Nitanda H; Taguchi R; Yanagihara A; Sakaguchi H; Ishida H; Kaneko K
    Kyobu Geka; 2019 Jan; 72(1):17-22. PubMed ID: 30765624
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.
    Santos R; Colonias A; Parda D; Trombetta M; Maley RH; Macherey R; Bartley S; Santucci T; Keenan RJ; Landreneau RJ
    Surgery; 2003 Oct; 134(4):691-7; discussion 697. PubMed ID: 14605631
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer.
    Al-Thani S; Nasar A; Villena-Vargas J; Harrison S; Lee B; Port JL; Altorki N; Chow OS
    J Thorac Dis; 2024 Mar; 16(3):1875-1884. PubMed ID: 38617767
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of target area selection in
    Yan WL; Lv JS; Guan ZY; Wang LY; Yang JK; Liang JX
    Thorac Cancer; 2017 May; 8(3):147-152. PubMed ID: 28217920
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    Latif MJ; Tan KS; Molena D; Huang J; Bott MJ; Park BJ; Adusumilli PS; Rusch VW; Bains MS; Downey RJ; Jones DR; Isbell JM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2469-2477.e10. PubMed ID: 30902468
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancer.
    Ghosh S; Sujendran V; Alexiou C; Beggs L; Beggs D
    Eur J Cardiothorac Surg; 2003 Dec; 24(6):1002-7. PubMed ID: 14643820
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study.
    Nori D; Li X; Pugkhem T
    J Surg Oncol; 1995 Dec; 60(4):257-61. PubMed ID: 8551736
    [TBL] [Abstract][Full Text] [Related]  

  • 99. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
    Chen H; Louie AV
    Curr Treat Options Oncol; 2016 Jun; 17(6):27. PubMed ID: 27098533
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Radical sublobar resection for small-diameter lung cancers.
    Okada M
    Thorac Surg Clin; 2013 Aug; 23(3):301-11. PubMed ID: 23931014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.